Cerium dioxide, a Jekyll and Hyde nanomaterial, can increase basal and decrease elevated inflammation and oxidative stress

Nanomedicine. 2022 Jul:43:102565. doi: 10.1016/j.nano.2022.102565. Epub 2022 May 17.

Abstract

It was hypothesized that the catalyst nanoceria can increase inflammation/oxidative stress from the basal and reduce it from the elevated state. Macrophages clear nanoceria. To test the hypothesis, M0 (non-polarized), M1- (classically activated, pro-inflammatory), and M2-like (alternatively activated, regulatory phenotype) RAW 264.7 macrophages were nanoceria exposed. Inflammatory responses were quantified by IL-1β level, arginase activity, and RT-qPCR and metabolic changes and oxidative stress by the mito and glycolysis stress tests (MST and GST). Morphology was determined by light microscopy, macrophage phenotype marker expression, and a novel three-dimensional immunohistochemical method. Nanoceria blocked IL-1β and arginase effects, increased M0 cell OCR and GST toward the M2 phenotype and altered multiple M1- and M2-like cell endpoints toward the M0 level. M1-like cells had greater volume and less circularity/roundness. M2-like cells had greater volume than M0 macrophages. The results are overall consistent with the hypothesis.

Keywords: Cerium; Morphological and microscopic findings; Nanoparticles; Oxygen consumption; RAW 264.7 cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Arginase* / metabolism
  • Cerium
  • Humans
  • Inflammation
  • Nanostructures*
  • Oxidative Stress

Substances

  • Cerium
  • ceric oxide
  • Arginase